For research use only.
Verified Samples |
Verified Samples in IHC: Human thyroid cancer, Human ovarian cancer |
Dilution | IHC 1:30-1:150 |
Clonality | Polyclonal |
Immunogen | Synthetic peptide of human CLK2 |
Abbre | CLK2 |
Synonyms | CDC like kinase 2, CDC-like kinase 2, CLK 2, CLK kinase, CLK2, Clk2 Scamp3, Dual specificity protein kinase CLK2, Tu52, hCLK 2, hCLK2 |
Swissprot | |
Cellular Localization | Nucleus. |
Concentration | 0.5 mg/mL |
Buffer | PBS with 0.05% NaN3 and 40% Glycerol,pH7.4 |
Purification Method | Antigen affinity purification |
Research Areas | Cancer, Cell Biology, Epigenetics and Nuclear Signaling, Signal Transduction |
Conjugation | Unconjugated |
Storage | Store at -20°C Valid for 12 months. Avoid freeze / thaw cycles. |
Shipping | The product is shipped with ice pack,upon receipt,store it immediately at the temperature recommended. |
background | This gene encodes a dual specificity protein kinase that phosphorylates serine/threonine and tyrosine-containing substrates.Activity of this protein regulates serine- and arginine-rich (SR) proteins of the spliceosomal complex, thereby influencing alternative transcript splicing.Chromosomal translocations have been characterized between this locus and the PAFAH1B3 (platelet-activating factor acetylhydrolase 1b, catalytic subunit 3 (29kDa)) gene on chromosome 19, resulting in the production of a fusion protein.Note that this gene is distinct from the TELO2 gene (GeneID:9894), which shares the CLK2 alias, but encodes a protein that is involved in telomere length regulation.There is a pseudogene for this gene on chromosome 7.Alternative splicing results in multiple transcript variants. |
Other Clones
{{antibodyDetailsPage.numTotal}} Results
-
{{item.title}}
Citations ({{item.publications_count}}) Manual MSDS
Cat.No.:{{item.cat}}
{{index}} {{goods_show_value}}
Other Formats
{{formatDetailsPage.numTotal}} Results
Unconjugated
-
{{item.title}}
Citations ({{item.publications_count}}) Manual MSDS
Cat.No.:{{item.cat}}
{{index}} {{goods_show_value}}
-
{{item.title}}
IF:{{item.impact}}
Journal:{{item.journal}}
DOI:{{item.doi}}
-
Q{{(FAQpage.currentPage - 1)*pageSize+index+1}}:{{item.name}}
{{item.content}}